The new patent regime is challenging the Indian biopharm industry to transition from generics to novel products.
Rakhi Rashmi
Advertisement
Research Scholar at Jawaharlal Nehru University
Articles by Rakhi Rashmi
Advertisement
Latest Updated Articles
Biopharmaceuticals in India: Evolving from Generics to Innovator DrugsPublished: April 1st 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
3
Welcome to CPHI Frankfurt 2025
4
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
5
